ELEVATE-HFpEF Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 700 participants.
Also called NCT06678841
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 700 participants
- Registry
-
NCT06678841
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hong Kong SAR China, Japan, Malaysia, Norway, Slovenia, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06678841. Randomized; double masking; primary purpose treatment. Start 2025-07-09 (actual); primary completion 2028-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ELEVATE-HFpEF Clinical Study
- Acronym
- ELEVATE-HFpEF
- Intervention (Device)
- Personalized cardiac pacing
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct06678841- Content hash
6e61466e9c549eedeb90f2d847b638f51e2aeea07039b1b8f0f8f51a05afeb7a